stock
Acrivon Therapeutics, Inc. Common Stock
NASDAQ | ACRV
2.43
USD
+$0.00
(+0.00%
)At Close (As of Nov 18, 2025)
$74.86M
Market Cap
-
P/E Ratio
-2.24
EPS
$8.00
52 Week High
$1.05
52 Week Low
HEALTHCARE
Sector
ACRV Chart
Recent Chart
Price Action
ACRV Technicals
ACRV Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $197M |
| Total Current Assets | $182M |
| Cash And Cash Equivalents At Carrying Value | $40M |
| Cash And Short Term Investments | $40M |
| Inventory | - |
| Current Net Receivables | - |
| Total Non Current Assets | $15M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | - |
| Intangible Assets Excluding Goodwill | - |
| Goodwill | - |
| Investments | - |
| Long Term Investments | $5.1M |
| Short Term Investments | $140M |
| Other Current Assets | $2.1M |
| Other Non Current Assets | - |
| Total Liabilities | $20M |
| Total Current Liabilities | $17M |
| Current Accounts Payable | $758K |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $1.1M |
| Total Non Current Liabilities | $2.6M |
| Capital Lease Obligations | $3.6M |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $3.6M |
| Other Current Liabilities | $15M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $177M |
| Treasury Stock | - |
| Retained Earnings | -$197M |
| Common Stock | $31K |
| Common Stock Shares Outstanding | $338M |
ACRV News
ACRV Profile
Acrivon Therapeutics, Inc. Common Stock Profile
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Acrivon Therapeutics, Inc. is a forward-looking biopharmaceutical company located in Watertown, Massachusetts, dedicated to pioneering precision oncology therapies that significantly enhance patient outcomes in cancer care. Utilizing its innovative proprietary platform, Acrivon is committed to developing personalized medicines aligned with specific genetic tumor profiles, which meets the increasing demand for targeted cancer treatments. With a strong emphasis on research and a promising pipeline, Acrivon offers an enticing investment prospect for institutional investors seeking to contribute to the evolution of advanced cancer therapies and personalized medicine.
LPTX +368.57%
$2.05
CANF +5.00%
$0.38
ASBP +15.77%
$0.10
NVDA -2.80%
$181.36
ONDS +25.33%
$7.84
PLUG +2.63%
$2.14
WTO -8.00%
$0.02
LOBO +27.77%
$0.50
VHAI -33.33%
$0.00
CHR +0.63%
$0.04
ASST +7.69%
$1.12
OLMA +136.38%
$20.14
CMND -21.84%
$0.21
TSLA -1.87%
$401.25
F +1.08%
$13.02
AXDX -61.36%
$0.03
PFE +1.47%
$25.45
SOFI -2.95%
$26.24
BITF +2.99%
$2.75
QUBT +7.30%
$12.34
INTC -1.09%
$34.33
AMZN -4.43%
$222.55
WBD +4.17%
$23.69
NIO -1.64%
$5.98
DNN -0.41%
$2.38
GRAB -0.18%
$5.32
ACHR +2.56%
$7.61
ETHD -8.08%
$5.23
SNAP +0.85%
$8.25
PLTR -2.28%
$167.33
WULF +8.59%
$12.00
BMNR
+4.29%
$32.28
ADAP -15.14%
$0.05
MARA +3.21%
$11.88
GOOGL -0.25%
$284.28
CAN +20.75%
$1.03
NOK -0.30%
$6.64
AAL +0.16%
$12.36
AAPL 0.00%
$267.44
AMD -4.25%
$230.29
CIFR +1.60%
$14.58
KVUE -0.06%
$16.23
RGTI +4.13%
$25.71
NFLX +3.44%
$114.09
HPE -1.55%
$20.90
ABEV -0.39%
$2.53
T +0.51%
$25.60
TLRY 0.00%
$1.03
RIVN +0.80%
$14.99
RMBL +60.50%
$3.21
BYND -3.84%
$1.01
RIG +1.22%
$4.13
LNW -3.71%
$86.22
ADD -25.47%
$0.05
IREN +3.03%
$48.85
GPUS
+0.84%
$0.24
RR +3.84%
$3.24
BAC -2.14%
$51.48
SRM +53.27%
$10.30
KXIN +2.14%
$0.29
RUBI
-4.22%
$0.16
BURU
-5.42%
$0.20
CLF +2.00%
$11.19
MSFT -2.69%
$493.79
PLTD +2.29%
$7.12
MU -5.55%
$228.50
CRWV
-0.57%
$74.90
LFS
+68.39%
$6.50
SOUN +0.87%
$11.53
APLT +4.99%
$0.29
QS +0.15%
$12.97
BTBT +3.47%
$2.38
EPSM
+91.54%
$2.72
GOOG -0.22%
$284.96
BBD -0.69%
$3.59
PCG -1.10%
$16.15
ONFO +11.48%
$0.94
BTG 0.00%
$3.99
BTE +3.97%
$3.14
WLGS -5.57%
$0.04
HOOD -1.44%
$114.30
MRK +3.84%
$96.43
SMCI +2.34%
$34.90
MTSR -0.35%
$70.50
TWOH
+4.16%
$0.00
QBTS +0.43%
$22.93
IONZ
-5.35%
$4.77
AMCR +0.17%
$8.46
APLD -0.41%
$22.84
EOSE +3.69%
$13.48
HIMS +1.91%
$36.26
HBAN +0.32%
$15.35
VALE 0.00%
$12.17
CGTL -11.32%
$0.71
CLSK +1.88%
$10.81
PLTZ
+4.50%
$7.42
CSCO -0.52%
$77.37
DVLT -6.16%
$1.75
RXRX +0.97%
$4.16
META -0.71%
$597.69
LPTX +368.57%
$2.05
CANF +5.00%
$0.38
ASBP +15.77%
$0.10
NVDA -2.80%
$181.36
ONDS +25.33%
$7.84
PLUG +2.63%
$2.14
WTO -8.00%
$0.02
LOBO +27.77%
$0.50
VHAI -33.33%
$0.00
CHR +0.63%
$0.04
ASST +7.69%
$1.12
OLMA +136.38%
$20.14
CMND -21.84%
$0.21
TSLA -1.87%
$401.25
F +1.08%
$13.02
AXDX -61.36%
$0.03
PFE +1.47%
$25.45
SOFI -2.95%
$26.24
BITF +2.99%
$2.75
QUBT +7.30%
$12.34
INTC -1.09%
$34.33
AMZN -4.43%
$222.55
WBD +4.17%
$23.69
NIO -1.64%
$5.98
DNN -0.41%
$2.38
GRAB -0.18%
$5.32
ACHR +2.56%
$7.61
ETHD -8.08%
$5.23
SNAP +0.85%
$8.25
PLTR -2.28%
$167.33
WULF +8.59%
$12.00
BMNR
+4.29%
$32.28
ADAP -15.14%
$0.05
MARA +3.21%
$11.88
GOOGL -0.25%
$284.28
CAN +20.75%
$1.03
NOK -0.30%
$6.64
AAL +0.16%
$12.36
AAPL 0.00%
$267.44
AMD -4.25%
$230.29
CIFR +1.60%
$14.58
KVUE -0.06%
$16.23
RGTI +4.13%
$25.71
NFLX +3.44%
$114.09
HPE -1.55%
$20.90
ABEV -0.39%
$2.53
T +0.51%
$25.60
TLRY 0.00%
$1.03
RIVN +0.80%
$14.99
RMBL +60.50%
$3.21
BYND -3.84%
$1.01
RIG +1.22%
$4.13
LNW -3.71%
$86.22
ADD -25.47%
$0.05
IREN +3.03%
$48.85
GPUS
+0.84%
$0.24
RR +3.84%
$3.24
BAC -2.14%
$51.48
SRM +53.27%
$10.30
KXIN +2.14%
$0.29
RUBI
-4.22%
$0.16
BURU
-5.42%
$0.20
CLF +2.00%
$11.19
MSFT -2.69%
$493.79
PLTD +2.29%
$7.12
MU -5.55%
$228.50
CRWV
-0.57%
$74.90
LFS
+68.39%
$6.50
SOUN +0.87%
$11.53
APLT +4.99%
$0.29
QS +0.15%
$12.97
BTBT +3.47%
$2.38
EPSM
+91.54%
$2.72
GOOG -0.22%
$284.96
BBD -0.69%
$3.59
PCG -1.10%
$16.15
ONFO +11.48%
$0.94
BTG 0.00%
$3.99
BTE +3.97%
$3.14
WLGS -5.57%
$0.04
HOOD -1.44%
$114.30
MRK +3.84%
$96.43
SMCI +2.34%
$34.90
MTSR -0.35%
$70.50
TWOH
+4.16%
$0.00
QBTS +0.43%
$22.93
IONZ
-5.35%
$4.77
AMCR +0.17%
$8.46
APLD -0.41%
$22.84
EOSE +3.69%
$13.48
HIMS +1.91%
$36.26
HBAN +0.32%
$15.35
VALE 0.00%
$12.17
CGTL -11.32%
$0.71
CLSK +1.88%
$10.81
PLTZ
+4.50%
$7.42
CSCO -0.52%
$77.37
DVLT -6.16%
$1.75
RXRX +0.97%
$4.16
META -0.71%
$597.69